customer.service@microbix.com 
+1-905-361-8910 +1-800-794-6694 (Toll Free)
Record Sales of $19.1 million, Net Earnings of $1.8 million MISSISSAUGA, December 22, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQX:...
Microbix Reports Record Sales for Fiscal 2022
read more
NEWS RELEASES
Microbix Presenting Test-Workflow Validation Results at EMMD
MSwab® & PROCEEDx™FLOQ® Supporting Self-Collection for HPV Screening Programs MISSISSAUGA, CANADA, October 6, 2022 – Microbix...
Microbix Announces Initiation of Normal Course Issuer Bid
Microbix to Repurchase up to 5% of its outstanding shares over 12 months MISSISSAUGA, CANADA, September 28, 2022 – Microbix Biosystems...
Microbix Presenting at Muskoka Capital Conference
Meetings with Growth-Oriented Investors, September 23-25, 2022 MISSISSAUGA, CANADA, September 21, 2022 - Microbix Biosystems Inc. (TSX:...
Microbix Reports Results for Q3 Fiscal 2022
Q3 Sales of $5.0 million, Q3 Net Earnings of $0.6 million MISSISSAUGA, August 11, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF,...
Microbix Executes Substantial QAPs Supply Agreement
Microbix QAPs to Support Molecular & Antigen Test Platforms for Multiple Diseases MISSISSAUGA, CANADA, August 10, 2022 – Microbix...
Microbix Presenting STI Multiplex Test Controls at AACC
Quality Control Materials for Genital Ulcer Disease Molecular Assays MISSISSAUGA, CANADA, July 26, 2022 – Microbix Biosystems Inc. (TSX:...
Microbix Presenting Test Validation Methods at AACC
Usage of QAPs to Validate Whole Workflow Quality Control of Testing MISSISSAUGA, CANADA, June 3, 2022 – Microbix Biosystems Inc. (TSX:...
Microbix Reports Record Results for Q2 Fiscal 2022
Record Q2 Sales of $4.9 million, Q2 Net Earnings of $0.7 million MISSISSAUGA, May 12, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQX:...
Microbix Presenting Omicron Test Control Results at CVS
QAPs Supporting Molecular Diagnostic Tests for Dominant COVID-variant MISSISSAUGA, CANADA, April 29, 2022 – Microbix Biosystems Inc. (TSX:...
Microbix Presenting at the 2022 Bloom Burton Conference
Healthcare Investor Conference in Toronto on May 2 & 3, 2022 MISSISSAUGA, CANADA, April 28, 2022 – Microbix Biosystems Inc. (TSX: MBX,...
Microbix Presenting Respiratory Virus Controls Data at Two Events
QAPs Supporting Tests That Simultaneously Detect Multiple Respiratory Viruses MISSISSAUGA, CANADA, April 19, 2022 – Microbix Biosystems...
